[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global GLP-1RA Drugs Supply, Demand and Key Producers, 2023-2029

July 2023 | 102 pages | ID: G7860A94FA19EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global GLP-1RA Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global GLP-1RA Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for GLP-1RA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1RA Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global GLP-1RA Drugs total production and demand, 2018-2029, (K Units)

Global GLP-1RA Drugs total production value, 2018-2029, (USD Million)

Global GLP-1RA Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1RA Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: GLP-1RA Drugs domestic production, consumption, key domestic manufacturers and share

Global GLP-1RA Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global GLP-1RA Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1RA Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global GLP-1RA Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly And Company, AstraZeneca, Merck, Innovent Biologics and Daoer Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1RA Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global GLP-1RA Drugs Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global GLP-1RA Drugs Market, Segmentation by Type
  • Oral Tablets
  • Injection
Global GLP-1RA Drugs Market, Segmentation by Application
  • Hypoglycemia
  • Weight Loss
  • Other
Companies Profiled:
  • Novo Nordisk
  • Eli Lilly And Company
  • AstraZeneca
  • Merck
  • Innovent Biologics
  • Daoer Bio
Key Questions Answered

1. How big is the global GLP-1RA Drugs market?

2. What is the demand of the global GLP-1RA Drugs market?

3. What is the year over year growth of the global GLP-1RA Drugs market?

4. What is the production and production value of the global GLP-1RA Drugs market?

5. Who are the key producers in the global GLP-1RA Drugs market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 GLP-1RA Drugs Introduction
1.2 World GLP-1RA Drugs Supply & Forecast
  1.2.1 World GLP-1RA Drugs Production Value (2018 & 2022 & 2029)
  1.2.2 World GLP-1RA Drugs Production (2018-2029)
  1.2.3 World GLP-1RA Drugs Pricing Trends (2018-2029)
1.3 World GLP-1RA Drugs Production by Region (Based on Production Site)
  1.3.1 World GLP-1RA Drugs Production Value by Region (2018-2029)
  1.3.2 World GLP-1RA Drugs Production by Region (2018-2029)
  1.3.3 World GLP-1RA Drugs Average Price by Region (2018-2029)
  1.3.4 North America GLP-1RA Drugs Production (2018-2029)
  1.3.5 Europe GLP-1RA Drugs Production (2018-2029)
  1.3.6 China GLP-1RA Drugs Production (2018-2029)
  1.3.7 Japan GLP-1RA Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 GLP-1RA Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 GLP-1RA Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World GLP-1RA Drugs Demand (2018-2029)
2.2 World GLP-1RA Drugs Consumption by Region
  2.2.1 World GLP-1RA Drugs Consumption by Region (2018-2023)
  2.2.2 World GLP-1RA Drugs Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1RA Drugs Consumption (2018-2029)
2.4 China GLP-1RA Drugs Consumption (2018-2029)
2.5 Europe GLP-1RA Drugs Consumption (2018-2029)
2.6 Japan GLP-1RA Drugs Consumption (2018-2029)
2.7 South Korea GLP-1RA Drugs Consumption (2018-2029)
2.8 ASEAN GLP-1RA Drugs Consumption (2018-2029)
2.9 India GLP-1RA Drugs Consumption (2018-2029)

3 WORLD GLP-1RA DRUGS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World GLP-1RA Drugs Production Value by Manufacturer (2018-2023)
3.2 World GLP-1RA Drugs Production by Manufacturer (2018-2023)
3.3 World GLP-1RA Drugs Average Price by Manufacturer (2018-2023)
3.4 GLP-1RA Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global GLP-1RA Drugs Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for GLP-1RA Drugs in 2022
  3.5.3 Global Concentration Ratios (CR8) for GLP-1RA Drugs in 2022
3.6 GLP-1RA Drugs Market: Overall Company Footprint Analysis
  3.6.1 GLP-1RA Drugs Market: Region Footprint
  3.6.2 GLP-1RA Drugs Market: Company Product Type Footprint
  3.6.3 GLP-1RA Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: GLP-1RA Drugs Production Value Comparison
  4.1.1 United States VS China: GLP-1RA Drugs Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: GLP-1RA Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1RA Drugs Production Comparison
  4.2.1 United States VS China: GLP-1RA Drugs Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: GLP-1RA Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1RA Drugs Consumption Comparison
  4.3.1 United States VS China: GLP-1RA Drugs Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: GLP-1RA Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1RA Drugs Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based GLP-1RA Drugs Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers GLP-1RA Drugs Production Value (2018-2023)
  4.4.3 United States Based Manufacturers GLP-1RA Drugs Production (2018-2023)
4.5 China Based GLP-1RA Drugs Manufacturers and Market Share
  4.5.1 China Based GLP-1RA Drugs Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers GLP-1RA Drugs Production Value (2018-2023)
  4.5.3 China Based Manufacturers GLP-1RA Drugs Production (2018-2023)
4.6 Rest of World Based GLP-1RA Drugs Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based GLP-1RA Drugs Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers GLP-1RA Drugs Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers GLP-1RA Drugs Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World GLP-1RA Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Oral Tablets
  5.2.2 Injection
5.3 Market Segment by Type
  5.3.1 World GLP-1RA Drugs Production by Type (2018-2029)
  5.3.2 World GLP-1RA Drugs Production Value by Type (2018-2029)
  5.3.3 World GLP-1RA Drugs Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World GLP-1RA Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hypoglycemia
  6.2.2 Weight Loss
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World GLP-1RA Drugs Production by Application (2018-2029)
  6.3.2 World GLP-1RA Drugs Production Value by Application (2018-2029)
  6.3.3 World GLP-1RA Drugs Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Novo Nordisk
  7.1.1 Novo Nordisk Details
  7.1.2 Novo Nordisk Major Business
  7.1.3 Novo Nordisk GLP-1RA Drugs Product and Services
  7.1.4 Novo Nordisk GLP-1RA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Novo Nordisk Recent Developments/Updates
  7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 Eli Lilly And Company
  7.2.1 Eli Lilly And Company Details
  7.2.2 Eli Lilly And Company Major Business
  7.2.3 Eli Lilly And Company GLP-1RA Drugs Product and Services
  7.2.4 Eli Lilly And Company GLP-1RA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Eli Lilly And Company Recent Developments/Updates
  7.2.6 Eli Lilly And Company Competitive Strengths & Weaknesses
7.3 AstraZeneca
  7.3.1 AstraZeneca Details
  7.3.2 AstraZeneca Major Business
  7.3.3 AstraZeneca GLP-1RA Drugs Product and Services
  7.3.4 AstraZeneca GLP-1RA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 AstraZeneca Recent Developments/Updates
  7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Merck
  7.4.1 Merck Details
  7.4.2 Merck Major Business
  7.4.3 Merck GLP-1RA Drugs Product and Services
  7.4.4 Merck GLP-1RA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Merck Recent Developments/Updates
  7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Innovent Biologics
  7.5.1 Innovent Biologics Details
  7.5.2 Innovent Biologics Major Business
  7.5.3 Innovent Biologics GLP-1RA Drugs Product and Services
  7.5.4 Innovent Biologics GLP-1RA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Innovent Biologics Recent Developments/Updates
  7.5.6 Innovent Biologics Competitive Strengths & Weaknesses
7.6 Daoer Bio
  7.6.1 Daoer Bio Details
  7.6.2 Daoer Bio Major Business
  7.6.3 Daoer Bio GLP-1RA Drugs Product and Services
  7.6.4 Daoer Bio GLP-1RA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Daoer Bio Recent Developments/Updates
  7.6.6 Daoer Bio Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 GLP-1RA Drugs Industry Chain
8.2 GLP-1RA Drugs Upstream Analysis
  8.2.1 GLP-1RA Drugs Core Raw Materials
  8.2.2 Main Manufacturers of GLP-1RA Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1RA Drugs Production Mode
8.6 GLP-1RA Drugs Procurement Model
8.7 GLP-1RA Drugs Industry Sales Model and Sales Channels
  8.7.1 GLP-1RA Drugs Sales Model
  8.7.2 GLP-1RA Drugs Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World GLP-1RA Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1RA Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1RA Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1RA Drugs Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1RA Drugs Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1RA Drugs Production by Region (2018-2023) & (K Units)
Table 7. World GLP-1RA Drugs Production by Region (2024-2029) & (K Units)
Table 8. World GLP-1RA Drugs Production Market Share by Region (2018-2023)
Table 9. World GLP-1RA Drugs Production Market Share by Region (2024-2029)
Table 10. World GLP-1RA Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GLP-1RA Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GLP-1RA Drugs Major Market Trends
Table 13. World GLP-1RA Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GLP-1RA Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World GLP-1RA Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GLP-1RA Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1RA Drugs Producers in 2022
Table 18. World GLP-1RA Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GLP-1RA Drugs Producers in 2022
Table 20. World GLP-1RA Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GLP-1RA Drugs Company Evaluation Quadrant
Table 22. World GLP-1RA Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1RA Drugs Production Site of Key Manufacturer
Table 24. GLP-1RA Drugs Market: Company Product Type Footprint
Table 25. GLP-1RA Drugs Market: Company Product Application Footprint
Table 26. GLP-1RA Drugs Competitive Factors
Table 27. GLP-1RA Drugs New Entrant and Capacity Expansion Plans
Table 28. GLP-1RA Drugs Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1RA Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1RA Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GLP-1RA Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GLP-1RA Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1RA Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1RA Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1RA Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GLP-1RA Drugs Production Market Share (2018-2023)
Table 37. China Based GLP-1RA Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1RA Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1RA Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1RA Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GLP-1RA Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1RA Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1RA Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1RA Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1RA Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GLP-1RA Drugs Production Market Share (2018-2023)
Table 47. World GLP-1RA Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1RA Drugs Production by Type (2018-2023) & (K Units)
Table 49. World GLP-1RA Drugs Production by Type (2024-2029) & (K Units)
Table 50. World GLP-1RA Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1RA Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1RA Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GLP-1RA Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GLP-1RA Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1RA Drugs Production by Application (2018-2023) & (K Units)
Table 56. World GLP-1RA Drugs Production by Application (2024-2029) & (K Units)
Table 57. World GLP-1RA Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1RA Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1RA Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GLP-1RA Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk GLP-1RA Drugs Product and Services
Table 64. Novo Nordisk GLP-1RA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table 68. Eli Lilly And Company Major Business
Table 69. Eli Lilly And Company GLP-1RA Drugs Product and Services
Table 70. Eli Lilly And Company GLP-1RA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Eli Lilly And Company Recent Developments/Updates
Table 72. Eli Lilly And Company Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca GLP-1RA Drugs Product and Services
Table 76. AstraZeneca GLP-1RA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck GLP-1RA Drugs Product and Services
Table 82. Merck GLP-1RA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 86. Innovent Biologics Major Business
Table 87. Innovent Biologics GLP-1RA Drugs Product and Services
Table 88. Innovent Biologics GLP-1RA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Innovent Biologics Recent Developments/Updates
Table 90. Daoer Bio Basic Information, Manufacturing Base and Competitors
Table 91. Daoer Bio Major Business
Table 92. Daoer Bio GLP-1RA Drugs Product and Services
Table 93. Daoer Bio GLP-1RA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Global Key Players of GLP-1RA Drugs Upstream (Raw Materials)
Table 95. GLP-1RA Drugs Typical Customers
Table 96. GLP-1RA Drugs Typical Distributors

LIST OF FIGURES

Figure 1. GLP-1RA Drugs Picture
Figure 2. World GLP-1RA Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1RA Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1RA Drugs Production (2018-2029) & (K Units)
Figure 5. World GLP-1RA Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World GLP-1RA Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1RA Drugs Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1RA Drugs Production (2018-2029) & (K Units)
Figure 9. Europe GLP-1RA Drugs Production (2018-2029) & (K Units)
Figure 10. China GLP-1RA Drugs Production (2018-2029) & (K Units)
Figure 11. Japan GLP-1RA Drugs Production (2018-2029) & (K Units)
Figure 12. GLP-1RA Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 15. World GLP-1RA Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 17. China GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 22. India GLP-1RA Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GLP-1RA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1RA Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1RA Drugs Markets in 2022
Figure 26. United States VS China: GLP-1RA Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1RA Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1RA Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1RA Drugs Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1RA Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1RA Drugs Production Market Share 2022
Figure 32. World GLP-1RA Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1RA Drugs Production Value Market Share by Type in 2022
Figure 34. Oral Tablets
Figure 35. Injection
Figure 36. World GLP-1RA Drugs Production Market Share by Type (2018-2029)
Figure 37. World GLP-1RA Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World GLP-1RA Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World GLP-1RA Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World GLP-1RA Drugs Production Value Market Share by Application in 2022
Figure 41. Hypoglycemia
Figure 42. Weight Loss
Figure 43. Other
Figure 44. World GLP-1RA Drugs Production Market Share by Application (2018-2029)
Figure 45. World GLP-1RA Drugs Production Value Market Share by Application (2018-2029)
Figure 46. World GLP-1RA Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. GLP-1RA Drugs Industry Chain
Figure 48. GLP-1RA Drugs Procurement Model
Figure 49. GLP-1RA Drugs Sales Model
Figure 50. GLP-1RA Drugs Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source


More Publications